A Clinical Study Report is judged on whether it holds up under scrutiny, not on how well it reads. Reviewers are looking for internal consistency between the protocol, the statistical analysis plan and the results, and for a narrative that does not overstate what the data actually shows.
Start from the protocol, not the database
Every CSR should be structurally traceable back to the objectives and endpoints defined in the protocol. When the report drifts from that structure, reviewers notice immediately.
Consistency beats elegance
Terminology, units and population definitions should be identical across every table, listing and narrative section. Inconsistencies, even minor ones, are one of the most common findings in CSR review.
Say what the data supports, and no more
Overreaching conclusions in the discussion section are a frequent, avoidable source of regulatory questions. A well-written CSR is precise about the limits of what the study can claim.
Write for a reviewer who has not lived inside the study
Authors who have worked on a trial for years often assume context that a reviewer does not have. Every abbreviation, every subgroup, every protocol deviation needs to be explained on its own terms.
Build in review cycles that catch structural issues early
Catching a structural inconsistency at the outline stage costs an afternoon. Catching it after the biostatistics team has finalised tables costs weeks.
When to bring in dedicated medical writing support
Many sponsors and CROs have deep therapeutic expertise but no in-house medical writing capacity, particularly for a first submission. Our medical writing services are built on scientific accuracy and regulatory consistency, from protocols and investigator brochures through to full clinical study reports.
If your team is building internal medical writing capability rather than outsourcing it, our Medical Writing course covers the same principles in a practical, self-paced format.